| __timestamp | Amicus Therapeutics, Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 20717000 | 2999000 |
| Thursday, January 1, 2015 | 47269000 | 10393000 |
| Friday, January 1, 2016 | 71151000 | 15994000 |
| Sunday, January 1, 2017 | 88671000 | 26975000 |
| Monday, January 1, 2018 | 127200000 | 39509000 |
| Tuesday, January 1, 2019 | 169861000 | 48869000 |
| Wednesday, January 1, 2020 | 156407000 | 42510000 |
| Friday, January 1, 2021 | 192710000 | 46105000 |
| Saturday, January 1, 2022 | 213041000 | 50513000 |
| Sunday, January 1, 2023 | 275270000 | 51292000 |
Cracking the code
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, Amicus Therapeutics, Inc. and Wave Life Sciences Ltd. have taken different paths in optimizing these costs. From 2014 to 2023, Amicus Therapeutics saw a staggering 1,230% increase in SG&A expenses, peaking at $275 million in 2023. In contrast, Wave Life Sciences Ltd. maintained a more conservative growth, with a 1,610% increase, reaching $51 million in the same year.
This divergence highlights Amicus's aggressive expansion strategy, while Wave Life Sciences focuses on lean operations. Investors and industry analysts should consider these trends when evaluating the companies' long-term sustainability and growth potential. As the biotech sector continues to evolve, the ability to manage SG&A costs effectively will remain a key differentiator.
SG&A Efficiency Analysis: Comparing Bristol-Myers Squibb Company and Wave Life Sciences Ltd.
Intra-Cellular Therapies, Inc. and Amicus Therapeutics, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Summit Therapeutics Inc. vs Wave Life Sciences Ltd. Trends and Insights
Who Optimizes SG&A Costs Better? Insmed Incorporated or Wave Life Sciences Ltd.
Bio-Techne Corporation or Amicus Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Wave Life Sciences Ltd. Trends and Insights
SG&A Efficiency Analysis: Comparing PTC Therapeutics, Inc. and Amicus Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of MorphoSys AG and Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc. and Soleno Therapeutics, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Amicus Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
Comparing SG&A Expenses: Amicus Therapeutics, Inc. vs Evotec SE Trends and Insights
Comparing SG&A Expenses: Vericel Corporation vs Wave Life Sciences Ltd. Trends and Insights